By Robert Barnes (Washington Post Staff Writer) -- The Supreme Court today declined to consider whether dying patients have a right to be treated with experimental drugs not yet approved by the Food and Drug Administration. The court, without comment or recorded dissent, let stand a ruling by the U.S. Court of Appeals for the D.C. Circuit, which said the terminally ill have no constitutional right to drugs the agency had considered safe enough for additional testing.
